Human pharyngeal microbiota in age-related macular degeneration
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Subjects
- Location of subjects
- Singapore
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Throat Gula,Throat,throat
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Age-related macular degeneration AAMD - Age related macular degeneration,AGE RELAT MACULOPATHIES,AGE RELAT MACULOPATHY,Age Related Macular Degeneration,age related macular degeneration,Age related macular degeneration (disorder) [Ambiguous],Age Related Maculopathies,age related Maculopathies,Age related maculopathy,age related maculopathy,age-related macular degeneration,Age-related macular degeneration (disorder),Age-Related Macular Degenerations,Age-Related Maculopathies,Age-Related Maculopathy,AMD,AMD - Age-related macular degeneration,Amended,ARMD,ARMD - Age-related macular degeneration,Degeneration, Age-Related Macular,Degeneration, Macular,Degenerations, Age-Related Macular,Degenerations, Macular,Dystrophies, Macular,Dystrophy, Macular,Macular Degeneration,Macular degeneration (disorder),Macular degeneration (senile) of retina, unspecified,MACULAR DEGENERATION NOS,Macular Degeneration, Age-Related,macular degeneration, age-related,Macular Degenerations,Macular Degenerations, Age-Related,Macular Dystrophies,Macular Dystrophy,MACULOPATHIES AGE RELAT,Maculopathies, Age Related,Maculopathies, Age-Related,MACULOPATHY AGE RELAT,Maculopathy, Age Related,Maculopathy, Age-Related,Senile macular degeneration,Senile macular degeneration of retina,Senile macular retinal degeneration,SMD - Senile macular degeneration,Unspecified senile macular degeneration,Age-related macular degeneration
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- AMD(Age-related macular degeneration)-positive
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with Age-related macular degeneration
- Group 0 sample size Number of subjects in the control (unexposed) group
- 386
- Group 1 sample size Number of subjects in the case (exposed) group
- 245
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V3-V6
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- raw counts
- Statistical test
- DESeq2
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
- Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
- age, sex
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
Signature 1
Source: Figure 2
Description: DESeq2 differential abundance analysis expressed as Log2FC comparison of AMD-positive samples and control samples.
Abundance in Group 1: increased abundance in AMD(Age-related macular degeneration)-positive
NCBI | Quality Control | Links |
---|---|---|
Gemella |
Revision editor(s): Anne-mariesharp
Signature 2
Source: Figure 2
Description: DESeq2 differential abundance analysis expressed as Log2FC comparison of AMD-positive samples and control samples.
Abundance in Group 1: decreased abundance in AMD(Age-related macular degeneration)-positive
NCBI | Quality Control | Links |
---|---|---|
Prevotella |
Revision editor(s): Anne-mariesharp
Experiment 2
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control ( - )
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- AMD(Age-related macular degeneration)-positive ( + )
Lab analysis
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- Linear Regression
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
Signature 1
Source: Figure 3, Supplementary Table 4
Description: Relative abundances of significant genera between case (Age-related macular degeneration - positive) and control samples
Abundance in Group 1: increased abundance in AMD(Age-related macular degeneration)-positive ( + )
NCBI | Quality Control | Links |
---|---|---|
Gemella | ||
Streptococcus |
Revision editor(s): Anne-mariesharp
Signature 2
Source: Figure 3, Supplementary Table 4
Description: Relative abundances of significant genera between case (Age-related macular degeneration - positive) and control samples
Abundance in Group 1: decreased abundance in AMD(Age-related macular degeneration)-positive ( + )
NCBI | Quality Control | Links |
---|---|---|
Prevotella | ||
Leptotrichia |
Revision editor(s): Anne-mariesharp
Experiment 3
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Microbiome Microbiome,microbiome
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Rest (The rest of the study population)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- High Prevotella
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Subjects with high relative abundance of Prevotella
- Group 0 sample size Number of subjects in the control (unexposed) group
- 604
- Group 1 sample size Number of subjects in the case (exposed) group
- 27
Lab analysis
Statistical Analysis
Signature 1
Source: Table 2
Description: Microbial genera significantly associated with high Prevotella relative abundance.
Abundance in Group 1: decreased abundance in High Prevotella
NCBI | Quality Control | Links |
---|---|---|
Streptococcus | ||
Porphyromonas | ||
Granulicatella | ||
Gemella |
Revision editor(s): Anne-mariesharp
Experiment 4
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- High Gemella
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Subjects with high relative abundance of Gemella
- Group 0 sample size Number of subjects in the control (unexposed) group
- 610
- Group 1 sample size Number of subjects in the case (exposed) group
- 21
Lab analysis
Statistical Analysis
Signature 1
Source: Table 3
Description: Microbial genera significantly associated with high Gemella relative abundance.
Abundance in Group 1: increased abundance in High Gemella
NCBI | Quality Control | Links |
---|---|---|
Aggregatibacter | ||
Filifactor | ||
Haemophilus |
Revision editor(s): Anne-mariesharp
Signature 2
Source: Table 3
Description: Microbial genera significantly associated with high Gemella relative abundance.
Abundance in Group 1: decreased abundance in High Gemella
NCBI | Quality Control | Links |
---|---|---|
Prevotella | ||
Veillonella |
Revision editor(s): Anne-mariesharp
Experiment 5
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Age-related macular degeneration AAMD - Age related macular degeneration,AGE RELAT MACULOPATHIES,AGE RELAT MACULOPATHY,Age Related Macular Degeneration,age related macular degeneration,Age related macular degeneration (disorder) [Ambiguous],Age Related Maculopathies,age related Maculopathies,Age related maculopathy,age related maculopathy,age-related macular degeneration,Age-related macular degeneration (disorder),Age-Related Macular Degenerations,Age-Related Maculopathies,Age-Related Maculopathy,AMD,AMD - Age-related macular degeneration,Amended,ARMD,ARMD - Age-related macular degeneration,Degeneration, Age-Related Macular,Degeneration, Macular,Degenerations, Age-Related Macular,Degenerations, Macular,Dystrophies, Macular,Dystrophy, Macular,Macular Degeneration,Macular degeneration (disorder),Macular degeneration (senile) of retina, unspecified,MACULAR DEGENERATION NOS,Macular Degeneration, Age-Related,macular degeneration, age-related,Macular Degenerations,Macular Degenerations, Age-Related,Macular Dystrophies,Macular Dystrophy,MACULOPATHIES AGE RELAT,Maculopathies, Age Related,Maculopathies, Age-Related,MACULOPATHY AGE RELAT,Maculopathy, Age Related,Maculopathy, Age-Related,Senile macular degeneration,Senile macular degeneration of retina,Senile macular retinal degeneration,SMD - Senile macular degeneration,Unspecified senile macular degeneration,Age-related macular degeneration
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control ( - )
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- L-AMD(Late Age-related macular degeneration)-positive
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with late-stage Age-related macular degeneration
- Group 0 sample size Number of subjects in the control (unexposed) group
- 386
- Group 1 sample size Number of subjects in the case (exposed) group
- 165
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 4, Supplementary Table 6
Description: Relative abundances of significant genera between controls and individuals with late AMD(Age-related macular degeneration)
Abundance in Group 1: increased abundance in L-AMD(Late Age-related macular degeneration)-positive
NCBI | Quality Control | Links |
---|---|---|
Streptococcus | ||
Gemella |
Revision editor(s): Anne-mariesharp
Signature 2
Source: Figure 4, Supplementary Table 6
Description: Relative abundances of significant genera between controls and individuals with late AMD(Age-related macular degeneration)
Abundance in Group 1: decreased abundance in L-AMD(Late Age-related macular degeneration)-positive
NCBI | Quality Control | Links |
---|---|---|
Prevotella | ||
Leptotrichia |
Revision editor(s): Anne-mariesharp
Experiment 6
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control (Healthy participants)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Case (Age-related macular degeneration patients)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with Age-related macular degeneration greater than 60years
- Group 0 sample size Number of subjects in the control (unexposed) group
- 180
- Group 1 sample size Number of subjects in the case (exposed) group
- 192
Lab analysis
Statistical Analysis
Signature 1
Source: Supplementary Table 5
Description: Association between microbial genera and AMD status in individuals >60 years. Genera with significantly different relative abundances in case/control conditions are shown.
Abundance in Group 1: increased abundance in Case (Age-related macular degeneration patients)
NCBI | Quality Control | Links |
---|---|---|
Streptococcus |
Revision editor(s): Anne-mariesharp
Signature 2
Source: Supplementary Table 5
Description: Association between microbial genera and AMD status in individuals >60 years. Genera with significantly different relative abundances in case/control conditions are shown.
Abundance in Group 1: decreased abundance in Case (Age-related macular degeneration patients)
NCBI | Quality Control | Links |
---|---|---|
Prevotella | ||
Leptotrichia |
Revision editor(s): Anne-mariesharp
Experiment 7
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Control ( - ) (Healthy participants)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Case ( + ) (Age-related macular degeneration patients)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with Age-related macular degeneration
- Group 0 sample size Number of subjects in the control (unexposed) group
- 20
- Group 1 sample size Number of subjects in the case (exposed) group
- 20
Lab analysis
- Sequencing type
- PCR
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- Not specified
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Not specified
Statistical Analysis
- Statistical test
- Mann-Whitney (Wilcoxon)
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.01
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- No
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
Signature 1
Source: Figure 5
Description: Differential abundance of selected microbial genera between disease groups based on qPCR-derived copy numbers
Abundance in Group 1: increased abundance in Case ( + ) (Age-related macular degeneration patients)
NCBI | Quality Control | Links |
---|---|---|
Streptococcus |
Revision editor(s): Anne-mariesharp
Signature 2
Source: Figure 5
Description: Differential abundance of selected microbial genera between disease groups based on qPCR-derived copy numbers
Abundance in Group 1: decreased abundance in Case ( + ) (Age-related macular degeneration patients)
NCBI | Quality Control | Links |
---|---|---|
Prevotella |
Revision editor(s): Anne-mariesharp